Clonal hematopoiesis is not significantly associated with COVID-19 disease severity
Yifan Zhou(National Institutes of Health), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Clifton L. Dalgard(Uniformed Services University of the Health Sciences), Helen C. Su(National Institutes of Health), Peter Openshaw(Imperial College London), Cynthia E. Dunbar(National Institutes of Health), L. Novik(National Institute of Allergy and Infectious Diseases), Anna L. Godfrey(University of Namur), Jérôme Hadjadj(Inserm), Alain Fischer(Université Claude Bernard Lyon 1), Luigi D. Notarangelo(National Institutes of Health), J. Kenneth Baillie(Roslin Institute), Aurélie Cobat(Délégation Paris 5), Kerry Dobbs(National Institute of Allergy and Infectious Diseases), Stephanie N. Rogers(Wellcome/MRC Cambridge Stem Cell Institute), Martin R. Gaudinski(National Institutes of Health), Andrea Biondi(Azienda Ospedaliera San Gerardo), Jacobus Preller(University of Cambridge), Malcolm G. Semple(University of Liverpool), Margarete A. Fabre(AstraZeneca (United Kingdom)), Luisa Imberti(University of Brescia), Ruba Shalhoub(National Heart Lung and Blood Institute), Ingelise J. Gordon(National Institute of Allergy and Infectious Diseases), Muxin Gu(Wellcome/MRC Cambridge Stem Cell Institute), Emmanuelle Jouanguy(Délégation Paris 5), Andrea Lisco(National Institute of Allergy and Infectious Diseases), Colin O. Wu(National Heart Lung and Blood Institute), Paolo Bonfanti(University of California San Diego), Shubha Anand(University of Cambridge), Frédéric Rieux‐Laucat(Inserm), Irini Sereti(National Institutes of Health), Shiqin Yu(National Institutes of Health), Laurent Abel(Délégation Paris 5), Ziad Mallat(Inserm), Arch Diangson(University of Cambridge), Yu Zhang(National Institute of Allergy and Infectious Diseases), Wenhua Lu(Cambridge University Hospitals NHS Foundation Trust), Benjamin Terrier(Inserm), Tae–Hoon Shin(National Institutes of Health), Larisa Strom(National Institute of Allergy and Infectious Diseases), Wenhan Deng(University of Cambridge), Pedro M. Quirós(École Polytechnique Fédérale de Lausanne), Matthew Cullen(Leeds Teaching Hospitals NHS Trust), Thomas J. Gniadek(Johns Hopkins University)
Cited by 25
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k